Wiebe Olijve
directors
bioinformatics and system biology
Aduro Biotech
Netherlands
Biography
Dr. Olijve is an experienced research leader. He came out of retirement to serve as CEO and co-founder of BioNovion (now Aduro Biotech Europe), a company focused on the development of B-select antibodies for the treatment of serious diseases. Prior to BioNovion, he was vice president of the Research Biologics Council at Schering-Plough Research Institute (now Merck Research Laboratories). Previously, he served as vice president and site head of Schering-Plough Biopharma.
Research Interest
Phylogenetics & Evolutionary Biology
